The company from the US state of Minnesota has received the government’s permission to release the first implantable device for weight loss. It uses electrical impulses, deceiving your brain and telling it that the stomach is full.
The US Food and Drug Administration has approved the use of the first Maestro System electronic anti-obesity gadget developed by EnteroMedics company; it happened just once over the last seven years. This chargeable device is considered a reverse obesity therapy, since it does not require complicated surgical installation into the digestive system and, unlike gastric shunting, creates no digestion barriers.
Maestro provides electrical stimulation of the vagus nerve of the body using a device similar to a pacemaker. This nerve regulates the digestive system. Thus there is a blocking signal between the stomach and the brain, which prevents the formation of the feeling of hunger and provides the feeling of satiety.
This helps the victims of obesity to reduce the daily intake of calories, providing a safe, healthy and lasting weight loss. The device is approved for use in patients older than 18 years, who tried different ways to treat obesity but failed during the last 5 years of their life. However, only clinically approved methods are meant here.
The patients should have a body mass index between 35 and 45 and at least one of the traditional obesity related diseases, such as type II diabetes, hypertension or high cholesterol.
